Total Payments
$6,597
2024 Payments
$997.96
Companies
37
Transactions
340
Medicare Patients
13,603
Medicare Billing
$534,392
Payment Breakdown by Category
Food & Beverage$6,523 (98.9%)
Gifts$59.40 (0.9%)
Education$15.21 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,523 | 337 | 98.9% |
| Gift | $59.40 | 1 | 0.9% |
| Education | $15.21 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,580 | 69 | $0 (2024) |
| ABBVIE INC. | $864.67 | 61 | $0 (2024) |
| Novo Nordisk Inc | $709.42 | 40 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $637.78 | 25 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $353.16 | 20 | $0 (2021) |
| Avanir Pharmaceuticals, Inc. | $249.64 | 20 | $0 (2022) |
| Genentech USA, Inc. | $222.93 | 8 | $0 (2021) |
| GlaxoSmithKline, LLC. | $215.84 | 15 | $0 (2024) |
| Lilly USA, LLC | $194.72 | 12 | $0 (2024) |
| Esperion Therapeutics, Inc. | $162.94 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $997.96 | 61 | ABBVIE INC. ($274.89) |
| 2023 | $568.64 | 32 | AbbVie Inc. ($287.80) |
| 2022 | $655.32 | 27 | Amgen Inc. ($284.28) |
| 2021 | $1,056 | 52 | Amgen Inc. ($200.35) |
| 2020 | $738.45 | 36 | Amgen Inc. ($212.34) |
| 2019 | $1,041 | 50 | Amgen Inc. ($556.67) |
| 2018 | $922.53 | 49 | AstraZeneca Pharmaceuticals LP ($277.47) |
| 2017 | $617.58 | 33 | SANOFI-AVENTIS U.S. LLC ($130.14) |
All Payment Transactions
340 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 12/04/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $5.43 | General |
| Category: Bone Health | ||||||
| 11/20/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.17 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.05 | General |
| Category: Inflammation | ||||||
| 11/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/29/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: Inflammation | ||||||
| 10/25/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $5.88 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: VACCINES | ||||||
| 10/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Cardio-renal | ||||||
| 10/15/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.03 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/27/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | Philips North America LLC | (CK7) Extended Holter (Device) | Food and Beverage | Cash or cash equivalent | $24.78 | General |
| Category: Medical Device | ||||||
| 09/26/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $8.53 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Respiratory | ||||||
| 09/24/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: Inflammation | ||||||
| 09/18/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $70.13 | General |
| Category: Diabetes | ||||||
| 09/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $8.64 | General |
| Category: Inflammation | ||||||
| 09/05/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: VACCINES | ||||||
| 08/29/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Endocrinology | ||||||
| 08/26/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Diabetes | ||||||
| 08/22/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Inflammation | ||||||
| 08/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.55 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 1,760 | 2,270 | $220,378 | $74,735 |
| 2022 | 45 | 3,321 | 5,535 | $340,104 | $132,808 |
| 2021 | 54 | 4,167 | 6,765 | $423,023 | $166,866 |
| 2020 | 57 | 4,355 | 7,038 | $433,026 | $159,983 |
Total Patients
13,603
Total Services
21,608
Medicare Billing
$534,392
Procedure Codes
186
All Medicare Procedures & Services
186 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 212 | 394 | $107,673 | $31,934 | 29.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 134 | 134 | $37,599 | $16,560 | 44.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 65 | 77 | $15,790 | $4,789 | 30.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 43 | 44 | $5,220 | $3,151 | 60.4% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 95 | 115 | $6,379 | $1,878 | 29.4% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 42 | 43 | $3,960 | $1,555 | 39.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 48 | 49 | $2,396 | $1,526 | 63.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 100 | 118 | $5,218 | $1,524 | 29.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 109 | 139 | $4,273 | $1,430 | 33.5% |
| 72081 | X-ray of entire middle and lower spine, 1 view | Office | 2023 | 44 | 44 | $4,400 | $1,330 | 30.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 82 | 110 | $3,150 | $1,047 | 33.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 107 | 130 | $3,049 | $982.90 | 32.2% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 31 | 36 | $2,733 | $904.49 | 33.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 85 | 104 | $1,509 | $856.80 | 56.8% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 25 | 28 | $3,115 | $759.72 | 24.4% |
| 82306 | Vitamin d-3 level | Office | 2023 | 24 | 26 | $1,675 | $728.80 | 43.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 48 | 67 | $2,254 | $624.66 | 27.7% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 29 | 51 | $2,180 | $617.50 | 28.3% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 78 | 136 | $1,036 | $433.35 | 41.8% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 61 | 67 | $1,081 | $379.22 | 35.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 12 | 12 | $552.24 | $370.05 | 67.0% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 48 | 54 | $713.35 | $274.32 | 38.5% |
| 84550 | Uric acid level, blood | Office | 2023 | 56 | 59 | $882.52 | $258.38 | 29.3% |
| 90471 | Administration of vaccine | Office | 2023 | 13 | 15 | $582.60 | $214.48 | 36.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 72 | 87 | $597.00 | $189.20 | 31.7% |
About Dr. Keith Beck, MD
Dr. Keith Beck, MD is a Emergency Medical Services healthcare provider based in San Antonio, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1740280999.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Keith Beck, MD has received a total of $6,597 in payments from pharmaceutical and medical device companies, with $997.96 received in 2024. These payments were reported across 340 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($6,523).
As a Medicare-enrolled provider, Beck has provided services to 13,603 Medicare beneficiaries, totaling 21,608 services with total Medicare billing of $534,392. Data is available for 4 years (2020–2023), covering 186 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medical Services
- Other Specialties General Practice
- Location San Antonio, TX
- Active Since 07/29/2005
- Last Updated 01/30/2023
- Taxonomy Code 207PE0004X
- Entity Type Individual
- NPI Number 1740280999
Products in Payments
- VRAYLAR (Drug) $772.24
- Ozempic (Drug) $430.52
- EVENITY (Biological) $393.72
- Aimovig (Biological) $333.25
- Otezla (Drug) $261.89
- Prolia (Biological) $199.75
- NUEDEXTA (Drug) $165.89
- FARXIGA (Drug) $148.91
- AFREZZA (Drug) $144.22
- Rybelsus (Drug) $138.34
- Esbriet (Biological) $125.00
- NURTEC ODT (Drug) $125.00
- NEXLIZET (Drug) $124.56
- QULIPTA (Drug) $120.76
- TOUJEO (Drug) $108.97
- UBRELVY (Drug) $106.16
- JARDIANCE (Drug) $103.86
- Victoza (Drug) $101.65
- HYPERLIPIDEMIA - DISEASE (Drug) $98.48
- Xofluza (Drug) $97.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medical Services Doctors in San Antonio
Miss. Shah-Hinan Ahmed, Md, MD
Emergency Medical Services — Payments: $211,289
Emergency Medical Services $211,289
Dr. Anthony Martinez, Md, MD
Emergency Medical Services — Payments: $3,230
Emergency Medical Services $3,230
Dr. Joseph Martin, M.d, M.D
Emergency Medical Services — Payments: $519.36
Emergency Medical Services $519.36
Ted Switzer, M.d, M.D
Emergency Medical Services — Payments: $287.03
Emergency Medical Services $287.03
John Smith, Md, MD
Emergency Medical Services — Payments: $154.29
Emergency Medical Services $154.29
Dr. Richard Holt, D.o, D.O
Emergency Medical Services — Payments: $103.53
Emergency Medical Services $103.53